For decades, India has treated anaemia as a problem of supply. More iron tablets. More fortified food and more schemes layered onto an already crowded nutrition architecture. But the numbers have barely budged. According to NFHS-5, over 57 per cent of Indian women and nearly 60 per cent of adolescent girls are anaemic \u2014 figures that have remained stubbornly high despite years of programme expansion.<\/p>\n\n\n\n
What has been missing is not intent, but design.<\/p>\n\n\n\n
A recent cluster-randomised trial conducted by the Indian Council of Medical Research\u2013National Institute of Nutrition (ICMR-NIN) in Telangana may finally offer the clearest empirical signal yet that India\u2019s anaemia response needs a structural reset. Published in BMJ Global Health<\/em>, the study evaluates a population-wide Screen and Treat for Anaemia Reduction (STAR)<\/strong> strategy \u2014 and its implications go well beyond supplementation.<\/p>\n\n\n\n The STAR model departs from India\u2019s prevailing approach in one critical way: it assumes that anaemia cannot be addressed effectively without first being identified, at scale, and in real time.<\/p>\n\n\n\n Conducted across 14 villages in Telangana, the study compared routine care under existing national programmes with a proactive, community-level screening and doorstep treatment strategy. Over 6,100 individuals aged six months to 50 years were screened using portable point-of-care haemoglobin analysers. Treatment was tailored: therapeutic iron\u2013folic acid (IFA) doses for those with anaemia, and prophylactic doses for those without, aligned with national guidelines.<\/p>\n\n\n\n The results are difficult to ignore.<\/p>\n\n\n\n Among adolescent girls aged 10\u201319 years, anaemia prevalence declined by 15.3 percentage points<\/strong>, with mean haemoglobin levels increasing by 0.73 g\/dL<\/strong>. Women of reproductive age also saw measurable gains, with a 4.4 percentage point reduction<\/strong> in anaemia prevalence. Overall anaemia prevalence in intervention clusters fell to 29.6 per cent<\/strong>, compared to 32.5 per cent<\/strong> in control areas.<\/p>\n\n\n\n In a policy landscape often dominated by modelling and assumptions, this is rare: direct, population-level evidence<\/strong> that proactive screening outperforms opportunistic, facility-based care.<\/p>\n\n\n\n India\u2019s flagship Anaemia Mukt Bharat strategy has expanded coverage across age groups, but its architecture remains largely prophylactic and episodic. Screening is often limited to pregnant women or conducted opportunistically when individuals access health facilities. This approach misses precisely those groups most at risk: adolescents, out-of-school girls and women whose daily labour leaves little time for clinic visits.<\/p>\n\n\n\n High-impact global research has long warned against this gap. Analyses in The Lancet Global Health<\/em> and BMJ<\/em> show that iron deficiency explains only about half of anaemia cases among women in low- and middle-income countries. Chronic inflammation, repeated infections, micronutrient interactions and cumulative dietary inadequacy account for the rest. Without systematic detection, these cases remain invisible.<\/p>\n\n\n\n The STAR trial demonstrates that anaemia is not failing to respond because interventions are ineffective, but because they are poorly targeted<\/strong>.<\/p>\n\n\n\n The study also surfaces a crucial constraint. Despite doorstep delivery and behaviour change communication, adherence to IFA remained modest \u2014 32 per cent for therapeutic doses<\/strong> and 47.5 per cent for prophylactic doses<\/strong>.<\/p>\n\n\n\n This finding aligns with a growing body of evidence in Public Health Nutrition<\/em> and Social Science & Medicine<\/em> that supplementation alone cannot overcome social, sensory, and behavioural barriers. Side effects, misconceptions, gender norms and competing priorities all shape adherence. Screening identifies anaemia; sustained engagement determines whether treatment works.<\/p>\n\n\n\n In other words, testing is necessary but not sufficient<\/strong>.<\/p>\n\n\n\n What the STAR model implicitly recognises \u2014 and what policy has been slow to accept \u2014 is that anaemia is a life-course condition, not a pregnancy-specific one.<\/p>\n\n\n\n By adolescence, many Indian girls have already accumulated years of nutritional deficit. Menstrual blood loss, growth spurts, early marriage and closely spaced pregnancies further deplete iron stores. Research in Nature Reviews Disease Primers<\/em> underscores that late intervention cannot fully reverse the neurocognitive and metabolic effects of early deficiency.<\/p>\n\n\n\n This is why upstream platforms matter. Schools, community centres and mobile health units offer continuity that antenatal clinics cannot. They also allow anaemia to be addressed alongside nutrition literacy, menstrual health, and dietary diversity \u2014 factors that shape long-term outcomes.<\/p>\n\n\n\nWhat the STAR trial changes<\/strong><\/h3>\n\n\n\n
Why current programmes plateau<\/strong><\/h3>\n\n\n\n
The compliance paradox<\/strong><\/h3>\n\n\n\n
Anaemia as a life-course condition<\/strong><\/h3>\n\n\n\n
Where civil society fits in<\/strong><\/h3>\n\n\n\n